Innovation in the Treatment of Persistent Pain in Adults With NF1: Implementation of the iCanCope Mobile Application- Clinical Trial
NCT04561765 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 122
Last updated 2025-03-30
Summary
To demonstrate the initial feasibility and determine preliminary impact on clinical outcomes of the iCanCope-NF program in a pilot RCT. If successful this pilot study will support conducting a larger randomized control trial (RCT). The primary research question is what is the feasibility of the iCanCope-NF program? The investigators define feasibility as (1) rates of accrual and dropout, daily log-ins, engagement, and outcome measures completed and (2) perceptions regarding intervention acceptability and satisfaction; and what are the levels of engagement. log-ins, with the intervention? The secondary questions are: (1) how does the iCanCope-NF program compare with the control condition in differences of pain and pain-related activity limitations, sleep functioning, emotional functioning (depression, anxiety), opioid usage, pain catastrophizing, self-efficacy, respondent burden (i.e. Physical Functioning, R, Vitality, Social Functioning, Role-Emotional, and Mental Health), and psychological flexibility immediately post-treatment (T2), (2) does the iCanCope-NF + CM increase the engagement of the iCanCope-NF program as compared to iCanCope-NF without CM, and do their corresponding levels of pain and pain-related activity decrease with CM?, and (3) do individuals with NF1 utilize the Mindfulness based alternative approaches (MBAA) to help reduce pain symptoms? The investigators hypothesize that by customizing and including MBAA to the program for adults with NF1, that individuals who engage regularly as seen through Analytics Platform for Evaluating Effective Engagement (APEEE) application, will acquire new sets of skills to facilitate pain management, while pain as reported with the Brief Pain Inventory will decrease.
Conditions
- Neurofibromatosis 1
- Chronic Pain
Interventions
- DEVICE
-
iCanCope
The iCanCope mobile and web-based self-management program has been empirically evaluated for multiple painful diseases
- DEVICE
-
iCanCope+Contingency Management
In addition to the iCanCope-NF activities outlined above, individuals will be rewarded with incentives (contingency management) such as points that are redeemable for prize-based gift card vouchers. Points will be accrued through access to new sections, daily check-ins, and engagement of the mobile application. Based on research, the total amount of money that can be earned by the patient over the course of the two months is 50 dollars USD.
Sponsors & Collaborators
-
United States Department of Defense
collaborator FED -
The Hospital for Sick Children
collaborator OTHER -
Connecticut Children's Medical Center
collaborator OTHER -
Yale University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- FACTORIAL
Eligibility
- Min Age
- 18 Years
- Max Age
- 72 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-03-01
- Primary Completion
- 2022-09-06
- Completion
- 2022-09-06
Countries
- United States
Study Locations
More Related Trials
-
A Decentralized Clinical Trial to Promote Evidence-Based Care for Underserved Patients With Neurofibromatosis 1
NCT06262113 ·Status: RECRUITING ·Phase: NA
-
Integrating Supportive Care in Cystic Fibrosis
NCT02668575 ·Status: COMPLETED ·Phase: NA
-
Cystic Fibrosis (CF) Leukocyte Genes as Biomarkers for Novel Therapies
NCT00727285 ·Status: COMPLETED
-
Study of Interferon Gamma-1b by Injection for the Treatment of Patients With Cystic Fibrosis
NCT00043342 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Diagnosis and Treatment of Patients With Cystic Fibrosis
NCT00001223 ·Status: TERMINATED
-
Interferon Gamma-1b by Inhalation for the Treatment of Patients With Cystic Fibrosis
NCT00043316 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Anti-inflammatory Pulmonal Therapy of Cystic Fibrosis (CF) Patients With Amitriptyline and Placebo
NCT01309178 ·Status: UNKNOWN ·Phase: PHASE2
-
Tailoring an Online Platform to Promote Evidence-Based Care for Adults With Neurofibromatosis 1 and Low Health Literacy
NCT07233408 ·Status: RECRUITING ·Phase: NA
-
Pilot Study to Evaluate a Voice Journaling Application in Adolescents With Cystic Fibrosis
NCT05420844 ·Status: COMPLETED ·Phase: NA
-
Pilot Study of a CF-specific CBT Intervention for Adolescents
NCT05271643 ·Status: COMPLETED ·Phase: NA
-
A Phase 2 Study Evaluating Safety and Tolerability of RCT2100 (CFTR mRNA) in Healthy Participants and in Participants With CF
NCT06237335 ·Status: RECRUITING ·Phase: PHASE2
-
Idiopathic Pulmonary Fibrosis: a Case-control Study
NCT00005295 ·Status: TERMINATED
-
Web-based Delivery of Effective Treatment for Growth in Cystic Fibrosis
NCT01686672 ·Status: COMPLETED ·Phase: NA
-
Phase I Study of the Third Generation Adenovirus H5.001CBCFTR in Patients With Cystic Fibrosis
NCT00004287 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Lung T1-MRI in Pediatric Cystic Fibrosis Patients
NCT04994301 ·Status: COMPLETED
-
STeP IT UP CF: STimulating ImProved Health And Well-being In CysTic Fibrosis
NCT04018495 ·Status: COMPLETED
-
Cystic Fibrosis Related Bone Disease: the Role of CFTR
NCT01549314 ·Status: COMPLETED
-
Statins To Treat Adult Cystic Fibrosis
NCT01092572 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Implementation of a Non-invasive Version of the Imaging β-adrenergic-dependent Sweat Secretion Test
NCT03584841 ·Status: UNKNOWN ·Phase: NA
-
A Study in Pediatric Patients With Cystic Fibrosis Lung Disease
NCT00130182 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Efficacy of Ivacaftor in Subjects With Cystic Fibrosis Who Have a 3849 + 10KB C→T or D1152H CFTR Mutation
NCT03068312 ·Status: COMPLETED ·Phase: PHASE3
-
19F MRI of Ventilation in Subjects With Cystic Fibrosis Undergoing Treatment for Pulmonary Exacerbation
NCT03497117 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
A Study in Adult and Pediatric Patients With Cystic Fibrosis
NCT00034515 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
PACE CF, a 3-session Mind-body Pain Management Program for Adults With Cystic Fibrosis
NCT06606457 ·Status: COMPLETED ·Phase: NA
-
Comparing Chest Images From MRI to CT in Patients With Cystic Fibrosis (CF)
NCT01860872 ·Status: COMPLETED